Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,800,012
-
Share change
-
-789,648
-
Total reported value
-
$18,171,330
-
Put/Call ratio
-
43%
-
Price per share
-
$2.33
-
Number of holders
-
51
-
Value change
-
-$1,689,187
-
Number of buys
-
24
-
Number of sells
-
24
Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) as of Q2 2015
As of 30 Jun 2015,
ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,800,012 shares.
The largest 10 holders included
BVF INC/IL, BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, Allianz Asset Management AG, Abingworth LLP, VANGUARD GROUP INC, Connor, Clark & Lunn Investment Management Ltd., FMR LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and BlackRock Group LTD.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.